Generation of MPS IIIA Induced Pluripotent Stem Cells for Correction Using CRISPR Cas9
CSEF · 2019 Biochemistry/ Molecular Biology
Overview
Objectives The objective of this project was to reprogram Mucopolysaccharidosis (MPS) IIIA human fibroblast cells into induced pluripotent stem cells, then correct the MPS IIIA genetic deficiency using CRISPR Cas9 technology in order to produce therapeutic neural stem cells. Methods MPS IIIA human fibroblasts, cell culture media, nucleofector machine and solution, mice DNA, PCR machine, primers and master mix, nuclease free water, pipettes, microscope, a hood. To perform this experiment, MPS IIIA human fibroblasts were grown with cell culture media, then nucleofected with DNA plasmids expressing transcription factors to reprogram them into iPSCs. Mice were genotyped so breeding pairs could produce knockout mice for future use when testing the treatment. Results The results showed that after growing the human fibroblasts, they were successfully reprogrammed into iPSCs. Multiple cell confluencies and types of media were used to find the optimal procedure for creating the iPSCs. The mice were successfully genotyped so the knockout genotype mice can be used for future testing of the treatment. Conclusions The hypothesis was partially proven because iPSC lines were able to be obtained, however they have not yet been corrected with CRISPR Cas9. After a large volume of iPSC clones is developed, CRISPR will be performed for gene correction. Once tested in mice and proven legitimate, this therapy could treat patients and provide significant insight into future gene therapies.
Summary statement
I reprogrammed MPS IIIA human fibroblasts into pluripotent stem cells which I will correct using CRISPR Cas9, then inject into mice I genotyped to test the treatment's effectiveness on the fatal genetic disorder MPS IIIA.
Help received
The lab facility where I had access to equipment and materials was LA Biomed. My mentor was Yewande Pearse. My mentor taught me specific laboratory procedures including feeding/ splitting cells and DNA extractions so I could then independently utilize these procedures in my project.
Competition history
- CSEF 2019
Resources
Related projects
ISEF · 2022
The Use of Prime Editing To Induce and Correct the CFTR-F508del Mutation in Induced Pluripotent Stem Cells
CSEF · 2017
A Novel Gene Therapy Using CRIPR/Cas9 Mediated Cellular Reprogramming
CSEF · 2008
Construction of an IGF-NAGLU Fusion Protein for Treatment of Sanfilippo B Syndrome
CSEF · 2013
Expression and Identification of N-acetylglucosamine-6-sulfatase (GNS): A Potential ERT Drug for Sanfilippo Syndrome D
ISEF · 2014
An Alternative to the Use of Embryonic Stem Cells
CSEF · 2018
Enhancing Gene Therapy through Targeted Delivery of CRIPSR/Cas9 in a Novel, Inexpensive Lipid Nanoparticle
ISEF · 2024
Creation of a Duchenne Muscular Dystrophy Myoblast Cell Culture Model by Knocking Out the Dystrophin Gene Using CRISPR/Cas-9 for High Throughput Drug Screening
CYSF · 2026
Evaluating PRPF4B Protein and mRNA Levels after CRISPR-Cas9 Mediated Heterozygous Knockout in Human iPSCs
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects